BPIFB1 promotes metastasis of hormone receptor‐positive breast cancer via inducing macrophage M2 ‐like polarization

Metastasis is an important factor affecting the prognosis of hormone receptor‐positive breast cancer (BC). However, the molecular basis for migration and invasion of tumor cells remains poorly understood. Here, we identify that bactericidal/permeability‐increasing‐fold‐containing family B member 1 (...

Full description

Saved in:
Bibliographic Details
Published inCancer science Vol. 114; no. 11; pp. 4157 - 4171
Main Authors Hu, Anbang, Liu, Yansong, Zhang, Hanyu, Wang, Ting, Zhang, Jiarui, Cheng, Weilun, Yu, Tianshui, Duan, Yunqiang, Feng, Jianyuan, Chen, Ziang, Ding, Yu, Li, Yanling, Li, Mingcui, Rong, Zhiyuan, Shang, Yuhang, Shakila, Suborna S., Zou, Yiyun, Ma, Fei, Guo, Baoliang
Format Journal Article
LanguageEnglish
Published Tokyo John Wiley & Sons, Inc 01.11.2023
John Wiley and Sons Inc
Subjects
Online AccessGet full text
ISSN1347-9032
1349-7006
1349-7006
DOI10.1111/cas.15957

Cover

Abstract Metastasis is an important factor affecting the prognosis of hormone receptor‐positive breast cancer (BC). However, the molecular basis for migration and invasion of tumor cells remains poorly understood. Here, we identify that bactericidal/permeability‐increasing‐fold‐containing family B member 1 (BPIFB1), which plays an important role in innate immunity, is significantly elevated in breast cancer and associated with lymph node metastasis. High expression of BPIFB1 and its coding mRNA are significantly associated with poor prognosis of hormone receptor‐positive BC. Using enrichment analysis and constructing immune infiltration evaluation, we predict the potential ability of BPIFB1 to promote macrophage M2 polarization. Finally, we demonstrate that BPIFB1 promotes the metastasis of hormone receptor‐positive BC by stimulating the M2‐like polarization of macrophages via the establishment of BC tumor cells/THP1 co‐culture system, qPCR, Transwell assay, and animal experiments. To our knowledge, this is the first report on the role of BPIFB1 as a tumor promoter by activating the macrophage M2 polarization in hormone receptor‐positive breast carcinoma. Together, these results provide novel insights into the mechanism of BPIFB1 in BC.
AbstractList Metastasis is an important factor affecting the prognosis of hormone receptor‐positive breast cancer (BC). However, the molecular basis for migration and invasion of tumor cells remains poorly understood. Here, we identify that bactericidal/permeability‐increasing‐fold‐containing family B member 1 (BPIFB1), which plays an important role in innate immunity, is significantly elevated in breast cancer and associated with lymph node metastasis. High expression of BPIFB1 and its coding mRNA are significantly associated with poor prognosis of hormone receptor‐positive BC. Using enrichment analysis and constructing immune infiltration evaluation, we predict the potential ability of BPIFB1 to promote macrophage M2 polarization. Finally, we demonstrate that BPIFB1 promotes the metastasis of hormone receptor‐positive BC by stimulating the M2‐like polarization of macrophages via the establishment of BC tumor cells/THP1 co‐culture system, qPCR, Transwell assay, and animal experiments. To our knowledge, this is the first report on the role of BPIFB1 as a tumor promoter by activating the macrophage M2 polarization in hormone receptor‐positive breast carcinoma. Together, these results provide novel insights into the mechanism of BPIFB1 in BC. BPIFB1 plays a pivotal role in promoting macrophage M2 polarization, which enhances the ability of hormone receptor‐positive breast cancer cells to metastasize.
Metastasis is an important factor affecting the prognosis of hormone receptor-positive breast cancer (BC). However, the molecular basis for migration and invasion of tumor cells remains poorly understood. Here, we identify that bactericidal/permeability-increasing-fold-containing family B member 1 (BPIFB1), which plays an important role in innate immunity, is significantly elevated in breast cancer and associated with lymph node metastasis. High expression of BPIFB1 and its coding mRNA are significantly associated with poor prognosis of hormone receptor-positive BC. Using enrichment analysis and constructing immune infiltration evaluation, we predict the potential ability of BPIFB1 to promote macrophage M2 polarization. Finally, we demonstrate that BPIFB1 promotes the metastasis of hormone receptor-positive BC by stimulating the M2-like polarization of macrophages via the establishment of BC tumor cells/THP1 co-culture system, qPCR, Transwell assay, and animal experiments. To our knowledge, this is the first report on the role of BPIFB1 as a tumor promoter by activating the macrophage M2 polarization in hormone receptor-positive breast carcinoma. Together, these results provide novel insights into the mechanism of BPIFB1 in BC.Metastasis is an important factor affecting the prognosis of hormone receptor-positive breast cancer (BC). However, the molecular basis for migration and invasion of tumor cells remains poorly understood. Here, we identify that bactericidal/permeability-increasing-fold-containing family B member 1 (BPIFB1), which plays an important role in innate immunity, is significantly elevated in breast cancer and associated with lymph node metastasis. High expression of BPIFB1 and its coding mRNA are significantly associated with poor prognosis of hormone receptor-positive BC. Using enrichment analysis and constructing immune infiltration evaluation, we predict the potential ability of BPIFB1 to promote macrophage M2 polarization. Finally, we demonstrate that BPIFB1 promotes the metastasis of hormone receptor-positive BC by stimulating the M2-like polarization of macrophages via the establishment of BC tumor cells/THP1 co-culture system, qPCR, Transwell assay, and animal experiments. To our knowledge, this is the first report on the role of BPIFB1 as a tumor promoter by activating the macrophage M2 polarization in hormone receptor-positive breast carcinoma. Together, these results provide novel insights into the mechanism of BPIFB1 in BC.
Metastasis is an important factor affecting the prognosis of hormone receptor‐positive breast cancer (BC). However, the molecular basis for migration and invasion of tumor cells remains poorly understood. Here, we identify that bactericidal/permeability‐increasing‐fold‐containing family B member 1 (BPIFB1), which plays an important role in innate immunity, is significantly elevated in breast cancer and associated with lymph node metastasis. High expression of BPIFB1 and its coding mRNA are significantly associated with poor prognosis of hormone receptor‐positive BC. Using enrichment analysis and constructing immune infiltration evaluation, we predict the potential ability of BPIFB1 to promote macrophage M2 polarization. Finally, we demonstrate that BPIFB1 promotes the metastasis of hormone receptor‐positive BC by stimulating the M2‐like polarization of macrophages via the establishment of BC tumor cells/THP1 co‐culture system, qPCR, Transwell assay, and animal experiments. To our knowledge, this is the first report on the role of BPIFB1 as a tumor promoter by activating the macrophage M2 polarization in hormone receptor‐positive breast carcinoma. Together, these results provide novel insights into the mechanism of BPIFB1 in BC.
Author Zou, Yiyun
Wang, Ting
Ma, Fei
Shang, Yuhang
Li, Mingcui
Yu, Tianshui
Chen, Ziang
Cheng, Weilun
Feng, Jianyuan
Duan, Yunqiang
Zhang, Hanyu
Shakila, Suborna S.
Zhang, Jiarui
Li, Yanling
Hu, Anbang
Liu, Yansong
Guo, Baoliang
Rong, Zhiyuan
Ding, Yu
AuthorAffiliation 1 Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
2 Department of General Surgery Daqing Oilfield General Hospital Daqing China
AuthorAffiliation_xml – name: 1 Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– name: 2 Department of General Surgery Daqing Oilfield General Hospital Daqing China
Author_xml – sequence: 1
  givenname: Anbang
  surname: Hu
  fullname: Hu, Anbang
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 2
  givenname: Yansong
  surname: Liu
  fullname: Liu, Yansong
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 3
  givenname: Hanyu
  surname: Zhang
  fullname: Zhang, Hanyu
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 4
  givenname: Ting
  surname: Wang
  fullname: Wang, Ting
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 5
  givenname: Jiarui
  surname: Zhang
  fullname: Zhang, Jiarui
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 6
  givenname: Weilun
  surname: Cheng
  fullname: Cheng, Weilun
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 7
  givenname: Tianshui
  surname: Yu
  fullname: Yu, Tianshui
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 8
  givenname: Yunqiang
  surname: Duan
  fullname: Duan, Yunqiang
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 9
  givenname: Jianyuan
  surname: Feng
  fullname: Feng, Jianyuan
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 10
  givenname: Ziang
  surname: Chen
  fullname: Chen, Ziang
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 11
  givenname: Yu
  surname: Ding
  fullname: Ding, Yu
  organization: Department of General Surgery Daqing Oilfield General Hospital Daqing China
– sequence: 12
  givenname: Yanling
  surname: Li
  fullname: Li, Yanling
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 13
  givenname: Mingcui
  surname: Li
  fullname: Li, Mingcui
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 14
  givenname: Zhiyuan
  surname: Rong
  fullname: Rong, Zhiyuan
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 15
  givenname: Yuhang
  surname: Shang
  fullname: Shang, Yuhang
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 16
  givenname: Suborna S.
  surname: Shakila
  fullname: Shakila, Suborna S.
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 17
  givenname: Yiyun
  surname: Zou
  fullname: Zou, Yiyun
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 18
  givenname: Fei
  surname: Ma
  fullname: Ma, Fei
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
– sequence: 19
  givenname: Baoliang
  orcidid: 0000-0002-4022-6739
  surname: Guo
  fullname: Guo, Baoliang
  organization: Department of General Surgery The Second Affiliated Hospital of Harbin Medical University Harbin China
BookMark eNp1kM9u1DAQhy1URP_AgTewxAWQ0jp2Escn1FYUKhXBAc7WxJnsuiR2sJ2tyolH4Bl5EtzdSogKLEu25G9-4_kOyZ7zDgl5XrLjMq8TA_G4rFUtH5GDUlSqkIw1e9u7LBQTfJ8cxnjNmGgqVT0h-0JKxnmjDsjN2afLi7OSzsFPPmGkEyaIedtI_UDXPky5Fw1ocE4-_Prxc_bRJrtB2gXMJDXgDAa6sUCt6xdj3YpOYIKf17BC-oHTXDTar0hnP0Kw3yFZ756SxwOMEZ_dn0fky8Xbz-fvi6uP7y7PT68KU7E6FT10iktTc9FVoh0UCIEcTG94U_VKSda2gg_YATNdW6GRvBSqrToUsmHt0Igj8nqXu7gZbm9gHPUc7AThVpdM39nT2Z7e2svwmx08L92EvUGXAvwp8GD13y_OrvXKb3JUIySr79q9vE8I_tuCMenJRoPjCA79EjVvm6rhnIkyoy8eoNd-CS7LyFQrlVCyZJk62VFZaIwBB21s2hrMH7DjP4d49aDi_wP_Bo4ltU8
CitedBy_id crossref_primary_10_1093_jleuko_qiae190
crossref_primary_10_1186_s12985_024_02432_9
crossref_primary_10_3168_jds_2024_24998
Cites_doi 10.1097/01.sla.0000245472.47748.ec
10.1089/omi.2011.0118
10.21037/atm-20-3462
10.1016/j.dci.2015.04.015
10.1007/s10555-016-9648-7
10.3322/caac.21217
10.1038/s41388-021-02079-8
10.2741/3723
10.7150/jca.13695
10.1016/j.addr.2017.04.010
10.1385/1-59259-759-9:061
10.3389/fimmu.2017.01106
10.3322/caac.21754
10.1016/j.envpol.2019.113587
10.3389/fimmu.2020.583084
10.1126/science.aay9189
10.3322/caac.21708
10.1093/bioinformatics/btz363
10.3390/md12105240
10.1080/2162402X.2022.2073010
10.1016/j.cell.2022.02.027
10.1186/s12859-020-03910-x
10.1016/j.yexcr.2016.03.010
10.1016/j.biomaterials.2018.01.040
10.1093/infdis/jir544
10.3390/cancers13215342
10.1038/s41580-018-0080-4
10.3322/caac.21660
10.1371/journal.pone.0184129
10.1111/j.1601-0825.2007.01429.x
10.1016/bs.acr.2016.11.007
10.1016/j.ajhg.2015.03.009
10.3831/KPI.2019.22.034
10.1016/j.biomaterials.2017.06.013
10.1155/2022/4487435
10.1126/scitranslmed.abf5473
10.1097/CM9.0000000000000132
10.1016/j.intimp.2022.109217
10.1016/j.biopha.2022.113774
10.1002/cbin.11528
10.1093/neuonc/nox081
10.1056/NEJM200002243420801
10.1038/s41419-018-0409-0
10.1155/2022/9999343
10.1016/j.addr.2022.114400
10.2174/0929867328666210811145043
10.1038/nrclinonc.2016.217
10.1056/NEJMoa050434
ContentType Journal Article
Copyright 2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Copyright_xml – notice: 2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
– notice: 2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
DBID AAYXX
CITATION
3V.
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
7X8
5PM
ADTOC
UNPAY
DOI 10.1111/cas.15957
DatabaseName CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (via ProQuest)
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Hu et al
EISSN 1349-7006
EndPage 4171
ExternalDocumentID 10.1111/cas.15957
PMC10637056
10_1111_cas_15957
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: ;
  grantid: 81872135; 82002791
– fundername: Distinguished Young Scientist Fund of the Second Affiliated Hospital of Harbin Medical University
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
24P
29B
2WC
31~
36B
3O-
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
88E
8FE
8FH
8FI
8FJ
8UM
930
A01
A03
AAFWJ
AAMMB
AAYXX
AAZKR
ABCQN
ABEML
ABUWG
ACCMX
ACSCC
ACXQS
ADBBV
ADKYN
ADPDF
ADZMN
AEFGJ
AENEX
AFBPY
AFEBI
AFFNX
AFKRA
AFPKN
AFZJQ
AGXDD
AIDQK
AIDYY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BBNVY
BCNDV
BENPR
BFHJK
BHPHI
BY8
CAG
CCPQU
CITATION
COF
CS3
D-6
D-7
D-E
D-F
DR2
DU5
E3Z
EBS
EJD
EMB
EMOBN
EX3
F00
F01
F04
F5P
FIJ
FYUFA
GODZA
GROUPED_DOAJ
HCIFZ
HF~
HMCUK
HOLLA
HYE
HZI
HZ~
IAO
IHR
ITC
IX1
J0M
K.9
K48
KQ8
LC2
LC3
LH4
LK8
LP6
LP7
LW6
M1P
M7P
MK4
N04
N05
N9A
O9-
OIG
OK1
OVD
P2P
P2X
P2Z
P4B
P4D
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PROAC
PSQYO
PUEGO
Q11
ROL
RPM
RX1
SJN
SUPJJ
SV3
TEORI
UB1
UKHRP
W8V
WIN
WOW
WQJ
WXI
X7M
XG1
ZXP
~IA
~WT
3V.
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQQKQ
PQUKI
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c405t-dab927c523b438f9a33e2acdc264d99708832feba0cb84ec7213984be37608f63
IEDL.DBID BENPR
ISSN 1347-9032
1349-7006
IngestDate Sun Oct 26 03:52:22 EDT 2025
Tue Sep 30 17:11:14 EDT 2025
Thu Oct 02 03:48:04 EDT 2025
Tue Oct 07 06:55:23 EDT 2025
Thu Apr 24 23:09:36 EDT 2025
Wed Oct 01 02:17:37 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
cc-by-nc-nd
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c405t-dab927c523b438f9a33e2acdc264d99708832feba0cb84ec7213984be37608f63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally: Anbang Hu, Yansong Liu, Hanyu Zhang
ORCID 0000-0002-4022-6739
OpenAccessLink https://www.proquest.com/docview/2887939710?pq-origsite=%requestingapplication%&accountid=15518
PMID 37702269
PQID 2887939710
PQPubID 4378882
PageCount 15
ParticipantIDs unpaywall_primary_10_1111_cas_15957
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10637056
proquest_miscellaneous_2864622031
proquest_journals_2887939710
crossref_citationtrail_10_1111_cas_15957
crossref_primary_10_1111_cas_15957
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-11-01
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: 2023-11-01
  day: 01
PublicationDecade 2020
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Hoboken
PublicationTitle Cancer science
PublicationYear 2023
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
References e_1_2_11_32_1
e_1_2_11_30_1
e_1_2_11_36_1
e_1_2_11_13_1
e_1_2_11_34_1
e_1_2_11_11_1
e_1_2_11_29_1
e_1_2_11_6_1
e_1_2_11_27_1
e_1_2_11_4_1
e_1_2_11_48_1
e_1_2_11_2_1
e_1_2_11_20_1
e_1_2_11_45_1
e_1_2_11_47_1
e_1_2_11_41_1
e_1_2_11_8_1
e_1_2_11_22_1
e_1_2_11_43_1
e_1_2_11_17_1
e_1_2_11_15_1
e_1_2_11_38_1
e_1_2_11_19_1
e_1_2_11_50_1
e_1_2_11_10_1
e_1_2_11_31_1
e_1_2_11_14_1
e_1_2_11_35_1
e_1_2_11_12_1
e_1_2_11_33_1
e_1_2_11_7_1
e_1_2_11_28_1
e_1_2_11_5_1
Min L (e_1_2_11_24_1) 2022; 14
e_1_2_11_26_1
e_1_2_11_3_1
e_1_2_11_49_1
e_1_2_11_21_1
e_1_2_11_44_1
e_1_2_11_46_1
e_1_2_11_25_1
e_1_2_11_40_1
e_1_2_11_9_1
e_1_2_11_23_1
e_1_2_11_42_1
e_1_2_11_18_1
e_1_2_11_16_1
e_1_2_11_37_1
e_1_2_11_39_1
References_xml – ident: e_1_2_11_8_1
  doi: 10.1097/01.sla.0000245472.47748.ec
– ident: e_1_2_11_29_1
  doi: 10.1089/omi.2011.0118
– ident: e_1_2_11_17_1
  doi: 10.21037/atm-20-3462
– volume: 14
  start-page: 1551
  year: 2022
  ident: e_1_2_11_24_1
  article-title: Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF‐kappaB/STAT3 signaling pathway
  publication-title: Am J Transl Res
– ident: e_1_2_11_13_1
  doi: 10.1016/j.dci.2015.04.015
– ident: e_1_2_11_50_1
  doi: 10.1007/s10555-016-9648-7
– ident: e_1_2_11_5_1
  doi: 10.3322/caac.21217
– ident: e_1_2_11_14_1
  doi: 10.1038/s41388-021-02079-8
– ident: e_1_2_11_40_1
  doi: 10.2741/3723
– ident: e_1_2_11_11_1
  doi: 10.7150/jca.13695
– ident: e_1_2_11_21_1
  doi: 10.1016/j.addr.2017.04.010
– ident: e_1_2_11_32_1
  doi: 10.1385/1-59259-759-9:061
– ident: e_1_2_11_49_1
  doi: 10.3389/fimmu.2017.01106
– ident: e_1_2_11_4_1
  doi: 10.3322/caac.21754
– ident: e_1_2_11_35_1
  doi: 10.1016/j.envpol.2019.113587
– ident: e_1_2_11_41_1
  doi: 10.3389/fimmu.2020.583084
– ident: e_1_2_11_43_1
  doi: 10.1126/science.aay9189
– ident: e_1_2_11_3_1
  doi: 10.3322/caac.21708
– ident: e_1_2_11_33_1
  doi: 10.1093/bioinformatics/btz363
– ident: e_1_2_11_12_1
  doi: 10.3390/md12105240
– ident: e_1_2_11_25_1
  doi: 10.1080/2162402X.2022.2073010
– ident: e_1_2_11_44_1
  doi: 10.1016/j.cell.2022.02.027
– ident: e_1_2_11_30_1
  doi: 10.1186/s12859-020-03910-x
– ident: e_1_2_11_34_1
  doi: 10.1016/j.yexcr.2016.03.010
– ident: e_1_2_11_22_1
  doi: 10.1016/j.biomaterials.2018.01.040
– ident: e_1_2_11_26_1
  doi: 10.1093/infdis/jir544
– ident: e_1_2_11_27_1
  doi: 10.3390/cancers13215342
– ident: e_1_2_11_48_1
  doi: 10.1038/s41580-018-0080-4
– ident: e_1_2_11_2_1
  doi: 10.3322/caac.21660
– ident: e_1_2_11_28_1
  doi: 10.1371/journal.pone.0184129
– ident: e_1_2_11_16_1
  doi: 10.1111/j.1601-0825.2007.01429.x
– ident: e_1_2_11_31_1
  doi: 10.1016/bs.acr.2016.11.007
– ident: e_1_2_11_15_1
  doi: 10.1016/j.ajhg.2015.03.009
– ident: e_1_2_11_36_1
  doi: 10.3831/KPI.2019.22.034
– ident: e_1_2_11_23_1
  doi: 10.1016/j.biomaterials.2017.06.013
– ident: e_1_2_11_20_1
  doi: 10.1155/2022/4487435
– ident: e_1_2_11_47_1
  doi: 10.1126/scitranslmed.abf5473
– ident: e_1_2_11_10_1
  doi: 10.1097/CM9.0000000000000132
– ident: e_1_2_11_37_1
  doi: 10.1016/j.intimp.2022.109217
– ident: e_1_2_11_39_1
  doi: 10.1016/j.biopha.2022.113774
– ident: e_1_2_11_46_1
  doi: 10.1002/cbin.11528
– ident: e_1_2_11_19_1
  doi: 10.1093/neuonc/nox081
– ident: e_1_2_11_6_1
  doi: 10.1056/NEJM200002243420801
– ident: e_1_2_11_9_1
  doi: 10.1038/s41419-018-0409-0
– ident: e_1_2_11_38_1
  doi: 10.1155/2022/9999343
– ident: e_1_2_11_42_1
  doi: 10.1016/j.addr.2022.114400
– ident: e_1_2_11_45_1
  doi: 10.2174/0929867328666210811145043
– ident: e_1_2_11_18_1
  doi: 10.1038/nrclinonc.2016.217
– ident: e_1_2_11_7_1
  doi: 10.1056/NEJMoa050434
SSID ssj0036494
Score 2.4569616
Snippet Metastasis is an important factor affecting the prognosis of hormone receptor‐positive breast cancer (BC). However, the molecular basis for migration and...
Metastasis is an important factor affecting the prognosis of hormone receptor-positive breast cancer (BC). However, the molecular basis for migration and...
SourceID unpaywall
pubmedcentral
proquest
crossref
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 4157
SubjectTerms Algorithms
Breast cancer
Breast carcinoma
Cell culture
Cloning
Estrogens
Genes
Genomes
Innate immunity
Leukocyte migration
Lung cancer
Lymph nodes
Lymphatic system
Macrophages
Medical prognosis
Metastases
Metastasis
mRNA
Original
ORIGINAL ARTICLES
Permeability
Polarization
Prognosis
Proteins
Software
Tumor cells
Tumors
SummonAdditionalLinks – databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1PT9swFH-CIsEu22CbFmCT2TjsEtTYTuwcYVrFJhVxoBKcIttxaEVJI5p0Yic-Ap-RT7LnJC0UbdNukfKcWPZ7z7-f_P4A7LOuNGhkgS-ljnxuFcenMPUzExrUZx6kwiU490-i4wH_cR6er8DePBfm6f29i7hxjb_wxA3FKqxFIcLtDqwNTk4PL2oixYUfd-smZK7Kni9QhdrqQUtjl8-cRyD5PAxyo8oLdftTjcdPzpjeq8dMnSa05OqgKvWB-fWscOM_p_8aXrYIkxw2KrEJKzbfgvV-e4f-BmZHp997RwEp6kA8OyXXtlSIEaejKZlkZIggdpJbgp7QFkjIH-7um8CumSXaRbCXxDhNuSGzkSLI6Cv87CW5Vq4X2BC9E-lTHDMeXVlSON7cJnq-hUHv29nXY7_tvuAbBHGlnyodU2GQqGrOZBYrxixVJjUIodI4FuieGM2sVl2jJbcGqSSLJdfWhdnILGLvoJPjfN8DybLA2EAKRtOUZyJWyNKQ5plQMi0oZx58me9PYtrS5K5DxjiZUxRcx6ReRw8-LUSLph7Hn4R255uctCY5TSi60xjRV9D1YG_xGo3J3ZCo3E4qJxPxiFJ0dB7IJeVY_MyV415-k4-GdVluJNdMIJ704PNCj_4-x-3_ktqBF66_fZP8uAud8qayHxAFlfpjawe_AYVJCFM
  priority: 102
  providerName: Unpaywall
Title BPIFB1 promotes metastasis of hormone receptor‐positive breast cancer via inducing macrophage M2 ‐like polarization
URI https://www.proquest.com/docview/2887939710
https://www.proquest.com/docview/2864622031
https://pubmed.ncbi.nlm.nih.gov/PMC10637056
https://doi.org/10.1111/cas.15957
UnpaywallVersion publishedVersion
Volume 114
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1349-7006
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036494
  issn: 1347-9032
  databaseCode: KQ8
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1349-7006
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036494
  issn: 1347-9032
  databaseCode: KQ8
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1349-7006
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036494
  issn: 1347-9032
  databaseCode: DOA
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1349-7006
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036494
  issn: 1347-9032
  databaseCode: RPM
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1349-7006
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036494
  issn: 1347-9032
  databaseCode: 7X7
  dateStart: 19880101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1349-7006
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036494
  issn: 1347-9032
  databaseCode: BENPR
  dateStart: 19880101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVWIB
  databaseName: KBPluse Wiley Online Library: Open Access
  customDbUrl:
  eissn: 1349-7006
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036494
  issn: 1347-9032
  databaseCode: AVUZU
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://www.kbplus.ac.uk/kbplus7/publicExport/pkg/559
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 1347-9032
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1349-7006
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0036494
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 1349-7006
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036494
  issn: 1347-9032
  databaseCode: 24P
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED9tnQS8ID5FYFTm44EXi8Z2Y-cBoRWtGkitqolK5alyHGet6NLQpkP899zlo9sQ8BJFsZVYOfvufvbd_QDeyp5xuMhCbkwSceWtwrt-yjPXdzifVZhqSnAejaOzqfoy688OYNzmwlBYZasTK0Wdrh3tkb8XuBpiNJ5h72PxgxNrFJ2uthQatqFWSD9UJcYO4UhQZawOHA1Ox5PzVjfLSMU1za3SPO5J0dQaotgeohhD20526qaFunY7_wyavLvLC_vrp12tblik4QO437iS7KSW_UM48PkjuDNqDssfw2Yw-TwchKyoIu78ll360qIzuF1u2TpjC_RW17lnqPJ8gcib1_FbV54lFKheMkcTYsOulpYhcN_hSy_YpSXKrwUqITYSfLX87llB4LjJ5nwC0-Hp109nvKFY4A49tZKnNomFdohGEyVNFlspvbAudegnpXGsUQdJkfnE9lxilHeIF2VsVOIplsZkkXwKnRzH-gxYloXOh0ZLkaYq07FFKIZYzvWNTLRQMoB37W-du6b-ONFgrOYtDkEJzCsJBPB637Woi278rdNxK5t5s-628-tZEsCrfTOuGDoGsblf76hPpCIhUJsFYG7JdP8xqrl9uyVfLqra24igpUanMYA3e_H_e4zP_z_GF3CP2Ovr1MZj6JSbnX-JPk6ZdOFQz3S3mb7daqeArucCn03Hk5NvvwEaWgNF
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGJjFeEFeRMcDcJF4sGttN7IcJUVjVsrWa0CbtLXNsh1br0tCkm_bn-G0cJ063IeBtb5FiJVbO7fvic0HoHesIDUYWEiHSiHCrOFx1Dcl0V4M-89DErsB5NI4GR_zbcfd4Df1qa2FcWmXrE2tHbeba_SP_SMEaJATPsPOp-Enc1Ch3utqO0FB-tILZqVuM-cKOPXt5ARSu3Bl-BXm_p7S_e_hlQPyUAaIBrFTEqFTSWAMhSzkTmVSMWaq00QAVjJQxmCGjmU1VR6eCWw2UiUnBU-vSSUQWMXjuHbTBGZdA_jZ6u-OD720sYBGXzVhdHhPZYdT3NnK5RG6kGWAJFxevR8QrmPtnkubmMi_U5YWaza5FwP4DdN9DV_y50bWHaM3mj9DdkT-cf4wWvYNhvxfios7wsyU-s5UC8FlOSzzP8ATQ8Ty3GFysLYDpkyZf7Nzi1CXGV1g7BVzg86nC09ws4aE_8JlyI8Ym4PTwiJLZ9NTiwpFxXz36BB3dysd-itZz2OszhLMs1DYUMaPG8CyWCqgfcEfdFSyNKWcB-tB-1kT7fudu7MYsaXkPSCCpJRCgN6ulRdPk42-LtlvZJN7Oy-RKKwP0enUbLNQdu6jczpduTcQjSsF7BkjckOnqZa7H9807-XRS9_oGxs5iAKkBersS_7_3uPX_Pb5Cm4PD0X6yPxzvPUf3KOC1pqxyG61Xi6V9AfiqSl96Jcbo5Lbt5jcUszug
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtQwFL0qRSpsEE81pYB5SWyiTmxPbC8QopRRhzJVF1SaXXAch4k6zYRJplV_ja_jOq-2CNh1FylWYuU-fE58fC_AGzaQBoMs8KWMQ59bzfFqmPipGRr0Zx4kwh1wnhyG-8f8y3Q4XYNf3VkYJ6vscmKdqJOFcf_IdyhGg8LFMxjspK0s4mhv9KH46bsOUm6ntWun0bjIgb04R_pWvh_voa3fUjr6_O3Tvt92GPANApXKT3SsqDBIxmLOZKo0Y5ZqkxiECYlSAkOQ0dTGemBiya1BusSU5LF1UhKZhgyfewtuC8aUkxOKaU_2WMhV01CXC18NGG2rGjkVkWtmhijCrYhX18JLgPunPPPOKi_0xbmez6-sfaP7cK8FreRj42UPYM3mD2Fj0m7LP4Ll7tF4tBuQotb22ZKc2koj7CyzkixSMkNcvMgtweRqC-T4fqMUO7MkdpL4ihjnektylmmS5ckKH_qDnGrXXGyG6Y5MqD_PTiwpHA1vz40-huMb-dRPYD3HuW4CSdPA2EAKRpOEp0JpJH3IGs1QslhQzjx4133WyLSVzl3DjXnUMR60QFRbwINX_dCiKe_xt0HbnW2iNsLL6NIfPXjZ38bYdBsuOreLlRsT8pBSzJseyGs27V_mqntfv5Nns7rKN3J1JhCeevC6N_-_57j1_zm-gA2Mlujr-PDgKdylCNSa85TbsF4tV_YZAqsqfl57MIHvNx0yvwGAuDk6
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1PT9swFH-CIsEu22CbFmCT2TjsEtTYTuwcYVrFJhVxoBKcIttxaEVJI5p0Yic-Ap-RT7LnJC0UbdNukfKcWPZ7z7-f_P4A7LOuNGhkgS-ljnxuFcenMPUzExrUZx6kwiU490-i4wH_cR6er8DePBfm6f29i7hxjb_wxA3FKqxFIcLtDqwNTk4PL2oixYUfd-smZK7Kni9QhdrqQUtjl8-cRyD5PAxyo8oLdftTjcdPzpjeq8dMnSa05OqgKvWB-fWscOM_p_8aXrYIkxw2KrEJKzbfgvV-e4f-BmZHp997RwEp6kA8OyXXtlSIEaejKZlkZIggdpJbgp7QFkjIH-7um8CumSXaRbCXxDhNuSGzkSLI6Cv87CW5Vq4X2BC9E-lTHDMeXVlSON7cJnq-hUHv29nXY7_tvuAbBHGlnyodU2GQqGrOZBYrxixVJjUIodI4FuieGM2sVl2jJbcGqSSLJdfWhdnILGLvoJPjfN8DybLA2EAKRtOUZyJWyNKQ5plQMi0oZx58me9PYtrS5K5DxjiZUxRcx6ReRw8-LUSLph7Hn4R255uctCY5TSi60xjRV9D1YG_xGo3J3ZCo3E4qJxPxiFJ0dB7IJeVY_MyV415-k4-GdVluJNdMIJ704PNCj_4-x-3_ktqBF66_fZP8uAud8qayHxAFlfpjawe_AYVJCFM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=BPIFB1+promotes+metastasis+of+hormone+receptor%E2%80%90positive+breast+cancer+via+inducing+macrophage+M2+%E2%80%90like+polarization&rft.jtitle=Cancer+science&rft.au=Hu%2C+Anbang&rft.au=Liu%2C+Yansong&rft.au=Zhang%2C+Hanyu&rft.au=Wang%2C+Ting&rft.date=2023-11-01&rft.issn=1347-9032&rft.eissn=1349-7006&rft.volume=114&rft.issue=11&rft.spage=4157&rft.epage=4171&rft_id=info:doi/10.1111%2Fcas.15957&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_cas_15957
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-9032&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-9032&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-9032&client=summon